These observations suggest that CD8_C8_CXCL13 cells might be more actively recruited to TLS and have more substantial anti-tumour potential than the exhausted CD8+ T cells in TCA of NPC, especially at the early stage. The gene discussed is CXCL13; the disease is nasopharyngeal carcinoma.